Innovative Eyewear (LUCY) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $0.84, +0.96% vs the prior close of $0.83.
- Volume 122.10K shares, 0.0x its 50-day average (light).
- New SEC filings: 8-K (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
LUCY rises 1.0% to $0.84. Closed at $0.84, +0.96% vs the prior close of $0.83. Day range $0.83–$0.87, opened at $0.83.
LUCY daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — LUCY rises 1.0% to $0.84
- Closed at $0.84, +0.96% vs the prior close of $0.83. Day range $0.83–$0.87, opened at $0.83.
- Volume was 122.10K shares, 0.0x its 50-day average of 4.46M — lighter than usual.
- Price is -2.7% vs its 50-day average ($0.87) and -15.8% vs its 200-day average ($1.00).
- 52-week range $0.65–$2.02; today's close sits at 14% of that range, 58.3% below the 52-week high.
- SEC filings that day: 8-K.
Oct 14, 2026 — LUCY dips 2.0% to $0.83, 3 down days in a row
- Closed at $0.83, -2.00% vs the prior close of $0.85. Day range $0.83–$0.88, opened at $0.86.
- Volume was 148.00K shares, 0.0x its 50-day average of 4.47M — lighter than usual.
- Price is -3.4% vs its 50-day average ($0.86) and -16.7% vs its 200-day average ($1.00).
- 52-week range $0.65–$2.05; today's close sits at 13% of that range, 59.3% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — LUCY slides 3.5% to $0.85
- Closed at $0.85, -3.51% vs the prior close of $0.88. Day range $0.85–$0.89, opened at $0.89.
- Volume was 113.30K shares, 0.0x its 50-day average of 4.47M — lighter than usual.
- Price is -1.2% vs its 50-day average ($0.86) and -15.2% vs its 200-day average ($1.00).
- 52-week range $0.65–$2.05; today's close sits at 14% of that range, 58.4% below the 52-week high.
Oct 12, 2026 — LUCY dips 2.2% to $0.88
- Closed at $0.88, -2.21% vs the prior close of $0.90. Day range $0.88–$0.94, opened at $0.93.
- Volume was 307.00K shares, 0.1x its 50-day average of 4.46M — lighter than usual.
- Price is +2.8% vs its 50-day average ($0.86) and -12.3% vs its 200-day average ($1.01).
- 52-week range $0.65–$2.05; today's close sits at 17% of that range, 56.9% below the 52-week high.
Oct 9, 2026 — LUCY rises 0.7% to $0.90
- Closed at $0.90, +0.67% vs the prior close of $0.90. Day range $0.90–$0.93, opened at $0.91.
- Volume was 73.20K shares, 0.0x its 50-day average of 4.46M — lighter than usual.
- Price is +5.6% vs its 50-day average ($0.86) and -10.6% vs its 200-day average ($1.01).
- 52-week range $0.65–$2.05; today's close sits at 18% of that range, 56.0% below the 52-week high.
Oct 8, 2026 — LUCY dips 1.6% to $0.90
- Closed at $0.90, -1.64% vs the prior close of $0.91. Day range $0.90–$0.93, opened at $0.91.
- Volume was 138.90K shares, 0.0x its 50-day average of 4.47M — lighter than usual.
- Price is +5.3% vs its 50-day average ($0.85) and -11.4% vs its 200-day average ($1.01).
- 52-week range $0.65–$2.05; today's close sits at 18% of that range, 56.2% below the 52-week high.
- SEC filings that day: 8-K.
- This was a results day: the company filed an earnings release (8-K Item 2.02).
Oct 7, 2026 — LUCY dips 1.4% to $0.91
- Closed at $0.91, -1.41% vs the prior close of $0.93. Day range $0.91–$0.93, opened at $0.92.
- Volume was 27.80K shares, 0.0x its 50-day average of 4.47M — lighter than usual.
- Price is +7.6% vs its 50-day average ($0.85) and -10.1% vs its 200-day average ($1.01).
- 52-week range $0.65–$2.05; today's close sits at 19% of that range, 55.5% below the 52-week high.
Oct 6, 2026 — LUCY jumps 3.9% to $0.93
- Closed at $0.93, +3.93% vs the prior close of $0.89. Day range $0.89–$0.95, opened at $0.89.
- Volume was 404.90K shares, 0.1x its 50-day average of 4.47M — lighter than usual.
- Price is +9.6% vs its 50-day average ($0.84) and -9.0% vs its 200-day average ($1.02).
- 52-week range $0.65–$2.05; today's close sits at 20% of that range, 54.9% below the 52-week high.
Oct 5, 2026 — LUCY ends flat (-0.2%) to $0.89
- Closed at $0.89, -0.22% vs the prior close of $0.89. Day range $0.88–$0.92, opened at $0.90.
- Volume was 175.90K shares, 0.0x its 50-day average of 4.47M — lighter than usual.
- Price is +5.8% vs its 50-day average ($0.84) and -12.7% vs its 200-day average ($1.02).
- 52-week range $0.65–$2.08; today's close sits at 17% of that range, 57.2% below the 52-week high.
- SEC filings that day: DEF 14A.
Oct 2, 2026 — LUCY slides 3.1% to $0.89
- Closed at $0.89, -3.15% vs the prior close of $0.92. Day range $0.89–$0.92, opened at $0.92.
- Volume was 139.60K shares, 0.0x its 50-day average of 4.47M — lighter than usual.
- Price is +6.6% vs its 50-day average ($0.84) and -12.7% vs its 200-day average ($1.02).
- 52-week range $0.65–$2.08; today's close sits at 17% of that range, 57.1% below the 52-week high.
LUCY latest news & SEC filings
Every SEC filing by or about LUCY in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Oct 8, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Oct 5, 2026 · DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Sep 24, 2026 · PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Sep 21, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 25, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 24, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Gayle Oswald sold 7,959 shares at $0.67 (≈$5.33K) on Aug 19, 2026
- Gayle Oswald sold 7,574 shares at $1.07 (≈$8.10K) on Apr 2, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 24, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Dabrowski Konrad sold 6,935 shares at $0.69 (≈$4.79K) on Aug 19, 2026
- Dabrowski Konrad sold 6,692 shares at $1.06 (≈$7.09K) on Apr 2, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 24, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Abondano Joaquin sold 5,020 shares at $0.68 (≈$3.41K) on Aug 19, 2026
- Abondano Joaquin sold 4,779 shares at $1.05 (≈$5.02K) on Apr 2, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 24, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Gross Harrison R. sold 5,722 shares at $0.71 (≈$4.06K) on Aug 19, 2026
- Gross Harrison R. sold 8,252 shares at $0.69 (≈$5.69K) on Aug 19, 2026
- Gross Harrison R. sold 13,764 shares at $1.07 (≈$14.73K) on Apr 2, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 14, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $1.01M (prior year $579.23K) (+74.5% vs Jun 30, 2025)
- Net income: -$1.67M (prior year -$2.11M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.26 (prior year -$0.66) (loss narrowed vs Jun 30, 2025)
Jul 23, 2026 · S-1 — Registration statement (S-1)
Registration statement (S-1) — registering new shares, usually for an IPO or offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 9, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade LUCY
- Last results release: Oct 8, 2026 (8-K Item 2.02). Previous ones: Jan 7, 2026. Based on that rhythm, the next report is likely around Jan 7, 2027 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.92% (largest 5.8%).
- Liquidity: about 172.74K shares (≈$145.62K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.84 vs a range of $0.65–$2.02 (14% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 12 open-market buys, 13 sales; latest: David Eric Cohen sold 6,136 shares on Aug 19, 2026.
- Latest filings: 8-K Oct 15, 2026; 8-K Oct 8, 2026; 10-Q Aug 14, 2026.
- Share count: 8.61M shares outstanding (Aug 11, 2026), +88.2% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Ophthalmic Goods.
LUCY market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 0.83 | 0.87 | 0.83 | 0.84 | 122.10K |
| Oct 14, 2026 | 0.86 | 0.88 | 0.83 | 0.83 | 148.00K |
| Oct 13, 2026 | 0.89 | 0.89 | 0.85 | 0.85 | 113.30K |
| Oct 12, 2026 | 0.93 | 0.94 | 0.88 | 0.88 | 307.00K |
| Oct 9, 2026 | 0.91 | 0.93 | 0.90 | 0.90 | 73.20K |
| Oct 8, 2026 | 0.91 | 0.93 | 0.90 | 0.90 | 138.90K |
| Oct 7, 2026 | 0.92 | 0.93 | 0.91 | 0.91 | 27.80K |
| Oct 6, 2026 | 0.89 | 0.95 | 0.89 | 0.93 | 404.90K |
| Oct 5, 2026 | 0.90 | 0.92 | 0.88 | 0.89 | 175.90K |
| Oct 2, 2026 | 0.92 | 0.92 | 0.89 | 0.89 | 139.60K |
| Oct 1, 2026 | 0.91 | 0.94 | 0.91 | 0.92 | 93.40K |
| Sep 30, 2026 | 0.91 | 0.95 | 0.90 | 0.91 | 91.50K |
| Sep 29, 2026 | 0.94 | 0.96 | 0.91 | 0.92 | 130.50K |
| Sep 28, 2026 | 0.95 | 0.96 | 0.94 | 0.96 | 53.60K |
| Sep 25, 2026 | 0.94 | 0.95 | 0.92 | 0.95 | 86.90K |
| Sep 24, 2026 | 0.90 | 0.94 | 0.90 | 0.93 | 212.60K |
| Sep 23, 2026 | 0.95 | 0.95 | 0.90 | 0.92 | 199.50K |
| Sep 22, 2026 | 0.93 | 0.96 | 0.92 | 0.94 | 198.30K |
| Sep 21, 2026 | 0.96 | 0.96 | 0.92 | 0.95 | 195.70K |
| Sep 18, 2026 | 0.89 | 0.97 | 0.89 | 0.95 | 542.10K |
About Innovative Eyewear
Innovative Eyewear (LUCY) is listed on the Nasdaq and classified by the SEC under “Ophthalmic Goods”. Its business address is in MIAMI, FL. State of incorporation: FL. Fiscal year ends December 31. SEC CIK 1808377.
LUCY board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Harrison R. Gross | Chief Executive Officer | Aug 24, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Joaquin Abondano | Chief Operating Officer | Aug 24, 2026 |
| David Eric Cohen | Chief Technology Officer | Aug 24, 2026 |
| Konrad Dabrowski | Chief AI & Growth Officer | Aug 24, 2026 |
| Oswald Gayle | Chief Financial Officer | Aug 24, 2026 |
| Harrison R. Gross | Chief Executive Officer | Aug 24, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 19, 2026 | David Eric Cohen | Sale | 6,136 | $0.68 |
| Aug 19, 2026 | Joaquin Abondano | Sale | 5,020 | $0.68 |
| Aug 19, 2026 | Oswald Gayle | Sale | 7,959 | $0.67 |
| Aug 19, 2026 | Harrison R. Gross | Sale | 5,722 | $0.71 |
| Aug 19, 2026 | Harrison R. Gross | Sale | 8,252 | $0.69 |
| Aug 19, 2026 | Konrad Dabrowski | Sale | 6,935 | $0.69 |
| Jul 6, 2026 | David Eric Cohen | Sale | 1,860 | $1.17 |
| Apr 9, 2026 | David Eric Cohen | Sale | 1,860 | $1.11 |
| Apr 2, 2026 | David Eric Cohen | Sale | 5,913 | $1.04 |
| Apr 2, 2026 | Joaquin Abondano | Sale | 4,779 | $1.05 |
| Apr 2, 2026 | Oswald Gayle | Sale | 7,574 | $1.07 |
| Apr 2, 2026 | Harrison R. Gross | Sale | 13,764 | $1.07 |
| Apr 2, 2026 | Konrad Dabrowski | Sale | 6,692 | $1.06 |
| Jan 21, 2026 | Harrison R. Gross | Buy | 1,500 | $1.32 |
| Jan 13, 2026 | Oswald Gayle | Buy | 300 | $1.69 |
LUCY financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $2.66M | $-7.59M | -1.90 | $-7.28M |
| Dec 31, 2024 | $1.64M | $-7.77M | -5.19 | $-6.74M |
| Dec 31, 2023 | $1.15M | $-6.66M | -10.87 | $-5.77M |
| Dec 31, 2022 | $659.79K | $-5.68M | -0.87 | $-3.22M |
| Dec 31, 2021 | $690.67K | $-3.24M | — | $-1.21M |
Latest balance sheet: total assets $7.47M, total liabilities $574.38K, cash $2.46M (as of Jun 30, 2026).
LUCY earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Oct 8, 2026 | 8-K Item 2.02 (results) | $0.90 |
| Jan 7, 2026 | 8-K Item 2.02 (results) | $1.74 |
Related stocks · Ophthalmic Goods
Cooper Companies (COO)Alcon (ALC)Warby Parker (WRBY)National Vision (EYE)Bausch & Lomb (BLCO)Staar Surgical (STAA)RxSight (RXST)Innovative Eyewear (LUCYW)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on LUCY
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.